Podcasts & Media

Philadelphia is a wonderland for unregulated “magic mushrooms.” Trip at your own risk.

Read More

Today’s illicit chemists can quickly cook up drugs far more dangerous than fentanyl.

Read More

A baffling overdose death took investigators to the frontier of ultra-potent synthetic drugs. The clues were hauntingly familiar.

Read More

K2 use is soaring behind bars, causing unpredictable behavior, violence and death. So, why can’t prison officials stop the flow of the drug?

Read More

At first, inmates were having seizures and growing terribly ill. Then they began dying. Cook County jail found itself on the forefront of an explosion of new lethal synthetic drugs soaking the pages of books, letters and other seemingly-harmless paper.

Read More

Keeping up to date with New Psychoactive Substances is hard! We've assembled a crack team of experts to help us do just that: Michael Evans-Brown from EMCDDA, Jared Brown from UNODC, and Alex Krotulski from CFSRE, moderated by TIAFT NPS Committee chair Svante Vikingsson.
LISTEN NOW

Pennsylvania’s unregulated hemp stores are booming, but tests show products are rife with toxic and illicit chemicals. Almost every sample The Inquirer tested was over the legal potency or contained mold or pesticides.

Read More

Keeping up to date with New Psychoactive Substances is hard! We've assembled a crack team of experts to help us do just that: Michael Evans-Brown from EMCDDA, Jared Brown from UNODC, and Alex Krotulski from CFSRE, moderated by TIAFT NPS Committee chair Svante Vikingsson.

In this episode we discuss: THC-P - fully synthetic or semi-synthetic cannabinoid?, the emerging etomidate and analogues, the intriguing mystery of BTMPS-adulterant or precursor, the 1000th NPS reported by EUDA and much more.
LISTEN NOW

In this episode Ryan interviews Dr. Alex Krotulski PhD from the Center for Forensic Science Research and Education. Together take a look at trends in novel opioids, benzodiazepines, stimulants, hallucinogens, synthetic cannabinoids, and "hemp products" that are showing up in your patients, drug products, and fatal overdoses. The conversation takes places around the Center for Forensic Science Research and Education quarterly report on Novel Psychoactive Substances found in patients and drug products.

The episode starts with a discussion of the novel benzodiazepines market, highlighting bromazolam and how long it may remain in the market. Then they discuss the opioids highlighting where we are seeing carfentanil, what is happening with Para Fluorofentanyl, and other super potent opioids emergening (such as N -pyrrolidino etonitazene). After a quick discussion of synthetic cathinone's and PCP/ketamine derivatives they jump to synthetic cannabinoids.
LISTEN NOW

Keeping up to date with New Psychoactive Substances is hard! We've assembled a crack team of experts to help us do just that: Michael Evans-Brown from EMCDDA, Conor Crean from UNODC, and Alex Krotulski from CFSRE.

These updates will be a regular part of our podcast schedule, letting you know about recent developments in NPS markets, detection and harms. In this episode we discuss an increasing trend of xylazine in fentanyl supplies, the recent scheduling of some NPS by the United Nations, and the emergence of semi-synthetic cannabinoids including HHC.
LISTEN NOW